Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Ji Young Ryu, Seon Ha Baek, Sejoong Kim

Clin Mol Hepatol. 2023;29(4):1048-1049. Published online August 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0261 Correction in: Clin Mol Hepatol 2024;30(1):134

View: 1574 Download: 29

Ji Young Ryu, Seon Ha Baek, Sejoong Kim

Clin Mol Hepatol. 2023;29(4):924-944. Published online June 5, 2023

DOI: https://doi.org/10.3350/cmh.2023.0090

View: 3150 Download: 235 Web of Science: 3 Crossref: 4

Jun Jae Kim, Jeong Han Kim, Ja Kyung Koo, Yun Jung Choi, Soon Young Ko, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2014;20(1):47-55. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.47

View: 6146 Download: 47 Web of Science: 5 Crossref: 2

Won Hyeok Choe

Clin Mol Hepatol. 2011;17(4):335-337. Published online December 26, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.4.335

View: 6236 Download: 49

1 |

Viewed By 5527	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4713	MAFLD: How is it different from NAFLD?
Viewed By 4446	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3644	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3616	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search